Form 4 for JSPR Jasper Therapeutics, Inc.
Accepted 2025-09-24 00:00:00 ET · period of report 2025-09-22 · accession 0001213900-25-091104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-24 | 2025-09-22 | JSPR | Lucas Svetlana | Dir | P - Purchase | $2.43 | +20.0K | 20.0K | New | +$48.6K |
| D | 2025-09-24 | 2025-09-22 | JSPR | Lucas Svetlana | Dir | P - Purchase | — | +20.0K | 20.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2025-09-22 | P | A | 20,000 | $2.43 | 20,000 | D | — | — | (F1) Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant. |
| 2 | Derivative | Common Stock Warrant (right to buy) | 2025-09-22 | P | A | 20,000 | — | 20,000 | D | $2.92 · 2026-03-22 to 2030-03-22 | 20,000 Voting Common Stock | (F1) Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant. |